Diethylamine

Diethylamine

SCHEMBL7213844

CC(C)O.CCNCC.CCO

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.53
TSHR P16473 6/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
CYP2C19 P33261 2/20 0.33
MEN1 O00255 1/20 0.33
GLA P06280 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL743633 0.93
Diethylamine SCHEMBL20400239 0.90 TP53 (0.57) TP53TSHRALDH1A1KDM4ELMNA
Hexane SCHEMBL2397294 0.89 TSHR (0.43) TP53TSHRALDH1A1KDM4ELMNA
Pentane SCHEMBL28094240 0.89 TSHR (0.43) TP53TSHRALDH1A1KDM4ELMNA
Diethylamine SCHEMBL538119 0.86
Propylene Glycol SCHEMBL7551796 0.84 TDP1 (0.62) TP53TSHRALDH1A1KDM4ELMNA
Diethylamine SCHEMBL9744225 0.83 TP53 (0.57) TP53TSHRALDH1A1KDM4ELMNA
Diethylamine SCHEMBL2240691 0.82 TP53 (0.67) TP53TSHRALDH1A1KDM4ECYP2C19
Diethylamine SCHEMBL11564718 0.82 TP53 (0.67) TP53TSHRALDH1A1KDM4ECYP2C19
Diethylamine SCHEMBL11582370 0.82 TP53 (0.67) TP53TSHRALDH1A1KDM4ECYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107167530-B Analysis method for determining stereoisomer and intermediate in solifenacin succinate 山东省药学科学院 2020-02-28 CN claimed
CN-107167530-A A kind of analysis method for determining butanedioic acid Solifenacin neutral body isomers and intermediate 山东省药学科学院 2017-09-15 CN claimed
CN-107167530-B Analysis method for determining stereoisomer and intermediate in solifenacin succinate 山东省药学科学院 2020-02-28 CN disclosed
CN-107167530-B Analysis method for determining stereoisomer and intermediate in solifenacin succinate 山东省药学科学院 2020-02-28 CN disclosed
CN-106008556-B Yi Dushaban and its isomers separation method 科贝源(北京)生物医药科技有限公司 2018-03-30 CN disclosed
CN-107167530-A A kind of analysis method for determining butanedioic acid Solifenacin neutral body isomers and intermediate 山东省药学科学院 2017-09-15 CN disclosed
CN-107167530-A A kind of analysis method for determining butanedioic acid Solifenacin neutral body isomers and intermediate 山东省药学科学院 2017-09-15 CN disclosed
EP-1104414-B1 ENANTIOSELECTIVE SYNTHESIS SCHERING CORP (US) 2003-02-12 EP disclosed
EP-1104414-A1 ENANTIOSELECTIVE SYNTHESIS SCHERING CORPORATION (US) 2001-06-06 EP disclosed
WO-2000009493-A1 ENANTIOSELECTIVE SYNTHESIS SCHERING CORPORATION (US) 2000-02-24 WO disclosed